Today: 9 April 2026
Subscribe
Browse Category

NYSE:NG 22 July 2025 - 12 February 2026

NovaGold Resources (NG) stock dips in premarket after 13% jump as Donlin Gold study draws focus

NovaGold Resources (NG) stock dips in premarket after 13% jump as Donlin Gold study draws focus

NovaGold shares fell 1.4% to $11.61 in premarket trading Thursday after a 12.7% surge the previous session. Investors are watching progress on the Donlin Gold feasibility study, led by Fluor and due in 2027, and tracking recent funding moves including a $310 million share sale. Director Daniel Muniz-Quintanilla disclosed a purchase of 22,470 shares at $8.94 each. NovaGold’s stake in Donlin recently increased to 60%.
12 February 2026
·
NovaGold stock tumbles 20% as U.S. Army Corps starts fresh Donlin Gold review; financing clock ticks

NovaGold stock tumbles 20% as U.S. Army Corps starts fresh Donlin Gold review; financing clock ticks

NovaGold shares fell 20.5% to $8.73 Friday after the U.S. Army Corps of Engineers launched a new environmental review of the Donlin Gold mine. The drop comes as NovaGold prepares a $300 million share sale set to close Feb. 5. Director Elaine J. Dorward-King sold over 33,000 shares earlier in the week. The Corps’ review could alter, uphold, or revoke existing federal permits for Donlin.
30 January 2026
NovaGold (NG) stock steadies as gold rebounds after CME margin hike; Fed minutes in focus

NovaGold (NG) stock steadies as gold rebounds after CME margin hike; Fed minutes in focus

NovaGold shares rose 0.5% to $9.54 by midday Tuesday after a 6.8% drop in the previous session. Spot gold rebounded 0.9% to $4,369.59 an ounce, recovering from its steepest loss since October. Traders awaited the Federal Reserve’s meeting minutes and monitored developments at the Donlin Gold project, where NovaGold’s stake recently increased to 60%.
30 December 2025
·····
NovaGold 2025: Is This Upstart Set to Strike Gold?

NovaGold 2025: Is This Upstart Set to Strike Gold?

NovaGold and Paulson completed a US$1 billion purchase of Barrick Gold’s 50% stake in the Donlin Gold project in mid-2025, giving NovaGold 60% and Paulson 40%. NovaGold reported a Q3 net loss of US$15.6 million with US$125 million in cash. NG shares rose about 138% over 12 months, hitting a US$8.09 high in September. Analysts set 12-month price targets between US$7 and US$11.
5 October 2025
··
Space Race Showdown, Mars Surprises & a New ‘Mini-Moon’ – Global Space News (Sept 15–16, 2025)

Space Race Showdown, Mars Surprises & a New ‘Mini-Moon’ – Global Space News (Sept 15–16, 2025)

China launched a test satellite for its satellite-internet constellation on Sept. 16, marking the 595th Long March rocket mission. NASA employees protested budget cuts and layoffs, while the agency barred Chinese nationals from its programs. SpaceX debuted Northrop Grumman’s Cygnus XL cargo ship to the ISS and received approval to double Falcon 9 launch rates. Astronomers confirmed asteroid 2025 PN7 as a quasi-moon co-orbiting Earth.
16 September 2025
···
B-2 Stealth Bomber’s Action-Packed 2025: Secret Strikes, High-Tech Upgrades & Pentagon Drama

B-2 Stealth Bomber’s Action-Packed 2025: Secret Strikes, High-Tech Upgrades & Pentagon Drama

Seven B-2 Spirit bombers struck Iran’s Fordow and Natanz nuclear sites on June 21–22, 2025, in Operation Midnight Hammer, dropping 14 GBU-57A/B bombs after launching from Whiteman AFB. A U.S. Navy submarine fired over two dozen Tomahawk missiles at Isfahan during the same operation. The B-2s returned to base by June 23. Nineteen B-2s remain in service, all based at Whiteman.
22 July 2025
·

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop